Lack of association between type of hepatitis C virus, serum load and severity of liver disease

Journal of Viral Hepatitis

Volumn 3, Issue 4, 1996, Pages 183-190

  Romeo, R ^a   Colombo, M ^a,d   Rumi, M ^a   Soffredini, R ^a   Del Ninno, E ^a   Donato, M F ^a   Russo, A ^b   Simmonds, P ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

HCV load; HCV type; Hepatitis C virus infection; Liver disease

Indexed keywords

HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; VIRUS RNA;

ADULT; AGED; ARTICLE; BIOPSY; BLOOD; CHRONIC DISEASE; FEMALE; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HOSPITALIZATION; HUMAN; IMMUNOLOGY; LIVER; MALE; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; POLYMERASE CHAIN REACTION; VIROLOGY;

ADULT; AGED; BIOPSY; CHRONIC DISEASE; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HUMANS; LIVER; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, VIRAL; SEVERITY OF ILLNESS INDEX;

EID: 0030179599     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2893.1996.tb00093.x     Document Type: Article

References (35)

1. Koretz RL, Abbey H, Coleman E, Gitnick G. Non-A, non-B post- transfusion hepatitis. Looking back in the second decade. Ann Intern Med 1993; 119: 110-115.
2. Alter MJ, Margolis HS, Krawczynski K et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899-1905.
3. Tassopoulos NC, Hatzakis A, Delladetsima I, Koutelou MG, Todoulos A, Miriagou V. Role of hepatitis C virus in acute non-A, non-B hepatitis in Greece: a 5-year prospective study. Gastroenterology 1992; 102: 969-72.
4. Genesca J, Esteban JI, Alter HJ. Blood-borne NANB hepatitis: hepatitis C. Semin Liver Dis 1991; 11: 147-164
5. Gordon SC, Elloway RS, Long JC, Dmuchowski CF. The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs intravenous drug use. Hepatology 1993; 18: 1338-1343.
6. Esteban JI, Lopez-Talavera JC, Genesca J et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med 1991; 115: 443-449.
7. Takada N, Takase S, Enomoto N, Takada A, Date T. Clinical backgrounds of the patients having different types of hepatitis C virus genome. J Hepatol 1992; 14: 35-40.
8. Pozzato G, Kaneko S, Moretti M et al. Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J Med Virol 1994; 43: 291-296.
9. Nousbaum JB, Pol S, Nalpas B et al. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995; 122: 161-168.
10. Kato N, Yokosuka O, Hosoda K, Ito Y, Ohto M, Omata M. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 1993; 18: 16-20.
11. Hagiwara H, Hayashi N, Mita E et al. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology 1993; 17: 545-550.
12. Gordon SC, Kodali VP, Silverman AL et al. Level of hepatitis C virus RNA and liver histology in chronic type C hepatitis. Am J Gastroenterol 1994; 89: 1458-1461.
13. Kanai K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1992; 339: 1543.
14. Tsubota A, Chayama K, Arase Y et al. Factors useful in predicting the response to interferon therapy in chronic hepatitis C. J Gatroenterol Hepatol 1993; 8: 535-539.
15. Hino K, Sainokami S, Shimoda K et al. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol 1994; 42: 299-305.
16. Yoshioka K, Kakumu S, Wakita T et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293-299.
17. Davis GL, Lau JYN, Urdea MS et al. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 1994; 19: 1337-1341.
18. Romeo R, Thiers V, Driss F, Berthelot P, Nalpas B, Brechot C. Hepatitis C virus RNA in serum of blood donors with or without elevated transaminase levels. Transfusion 1993; 33: 629-633.
19. Zaaijer HL, Cuypers HTM, Reesink HW, Winkel IN, Gerken G, Lelie PN. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993; 341: 722-724.
20. Lau JYN, Davis GL, Kniffen J et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: 1501-1504.
21. Simmonds P, Rose KA, Graham S et al. Mapping of serotype- specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1,2 and 3. J Clin Microbiol 1993; 31: 1493-1503.
22. Simmonds P, Holmes EC, Cha TA et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993; 74: 2391-2399.
23. Stuyver L, Rossau R, Wyseur A et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1093-1102.
24. Viazov S, Zibert A, Ramakrishnan K et al. Typing of hepatitis C virus isolates by DNA enzyme immunoassay. J Virol Meth 1994; 48: 81-92.
25. Bianchi L, de Groote J, Desmet VJ et al. Acute and chronic hepatitis revisitated: review by an international group. Lancet 1977; 2: 914-919.
26. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13: 372-374.
27. Pistello M, Maggi F, Vatteroni L et al. Prevalence of hepatitis C virus genotypes in Italy. J Clin Microbiol 1994; 32: 232-234.
28. Silini E, Bono F, Cividini A et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 1995; 21: 285-290.
29. Feray C, Gigou M, Samuel D et al. HCV type II has a more pathogenic course after liver transplantation (Abstract). Hepatology 1993; 18: 59A.
30. Prati D, Capelli C, Zanella A et al. Influence of different hepatitis C virus (HCV) genotypes on the course of asymptomatic HCV infection. Gastroenterology 1996; 110: 178-183.
31. Lau JYN, Mizokami M, Kolberg JA et al. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis 1995; 171: 281-289.
32. Biasin MR, Cavicchini A, Fiordalisi C, Marchelle G, Primi D, Infantolino D. Hepatitis C virus genotype 2c: typing and molecular characterization of a high prevalence subtype. Ital J Gastroenterol 1995; 27: 205.
33. Pol S, Thiers V, Nousbaum JB et al. The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology 1995; 108: 581-583.
34. Simmonds P. Variability of hepatitis C virus. Hepatology 1995; 21: 570-583.
35. Koziel MJ, Dudley D, Wong JT et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992; 149: 3339-3344.